Cancer Biotherapy and Radiopharmaceuticals · 2011 · 14 citations · 24 references
MedicineCancer BiologyOncologyApoptosisMolecular OncologyRadiobiologyApoptosis In CancerCellular Radiation ResponsePeroxiredoxin BiologyRadiation TherapyRadiation-induced Cell DeathCancer Cell ApoptosisCancer Cell RadiosensitivityCellular RadiosensitivityRadiation Sensitivity AssaysRadiation SensitizationRadiation-induced ApoptosisSingle-chain Variable Fragment DisplayTumor Radiosensitivity
BACKGROUND: Antibodies have been proved to be effective in cancer treatment. Peroxiredoxin I (Prx I) is a potential target for cancer radiotherapy. The aim of this article is to investigate the effect of a novel phage display single-chain variable fragment (scFv) antibody targeting Prx I on human lung carcinoma cell line A549 radiosensitivity and the underlying mechanisms. MATERIALS AND METHODS: A549 cell radiosensitivity was measured by colony-forming assay; cell cycle, cell apoptosis, and intracellular reactive oxygen species (ROS) level were determined by flow cytometer; RAD51 and γ-H2AX expression was evaluated by Western blot; and caspase 3 expression was determined by immunocytochemistry. A nude mouse bearing A549 tumor was established, and radiation sensitivity was measured to verify the in vitro data. RESULTS: Prx I scFv incubation significantly increased A549 cell radiosensitivity, and this might be through enhanced intracellular ROS level and caspase 3 expression. In addition, protein expression of radiosensitivity-related proteins, RAD51 and γ-H2AX, was also modulated. The nude mouse xenograft model bearing A549 tumor treated with Prx I scFv also exibited enhanced radiosensitivity compared with the PBS group. CONCLUSIONS: These results suggested that Prx I scFv could become a new therapy candidate for lung cancer radiotherapy.
24
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text
Gamma-H2AX - a novel biomarker for DNA double-strand breaks.
Linda J Kuo, Li‐Xi Yang · PubMed · 2008 · 1.2K citations
Tania Crombet, Marta Osorio, Teresa Cruz et al. · Journal of Clinical Oncology · 2004 · 300 citations · Full text